December 19, 2022

AMGEN INC. v. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. December 21, 2022

    Amgen Fights HHS' Drug Discount Claims At DC Court

    Amgen is the latest pharmaceutical giant to go to court over efforts by the U.S. Department of Health and Human Services to enforce a nationwide program that mandates discounted drug prices for people with low incomes and which Amgen says big pharmacy chains have "worked to dramatically expand" to the detriment of drugmakers.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS